Most older patients use hormone therapy to treat their breast cancer

Share this content:

the ONA take:

A seven-year study, published online in the Journal of Clinical Oncology, examined over a thousand elderly women with locally invasive breast cancer over some 78 institutions for the use of hormone therapy. Various factors such as frailty were factored into the analysis. The study results showed that the majority of women complied with their oncologist's recommendations and had their breast cancer treated with hormone therapy (aromatase inhibitor or tamoxifen).

Some variances were found: women 65 years of age and older were somewhat less likely to initiate and maintain treatment than women of middle age. White women were also more likely to have therpy than non-white women. The overall picture was promising, however, as the majority of women (non-initiation was 14%) began hormone treatment and maintained it for a length of time, if not always the full recommended time. Less than half of the women studied maintained the treatment for the recommended 5-year duration (discontinuation rate was 51.5 percent).

Most older patients use hormone treatment to treat their breast cancer
Most older patients use hormone treatment to treat their breast cancer
One of the most comprehensive looks at the use of hormone therapy in women over 65 with non-metastatic breast cancer found some welcome news. Except for frail patients, most participants in the large study complied with their oncologists' recommendations to treat their estrogen-positive breast cancer with hormone therapy - either an aromatase inhibitor or tamoxifen.
READ FULL ARTICLE From Science Codex
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs